Get Premium

Get Premium

Dominate Financial Markets with Stock Target Advisor Premium Features

Discover
Discover

Explore new stock opportunities and market trends for better investment decisions.
- Analyst Ratings & Stock Picks
- Top Picks By AI
- Latest Analyst Ratings
- Analyst Directory
- Worst Stocks
- Sector Ratings & Performance
- Smart Filters
- Best Penny Stocks
- Best Dividend Stocks
- Best Crypto Stocks
- Best Performing Stocks
- Worst Performing Stocks
- Highest Income ETFs
Research
Research

Access in-depth stock analysis and expert evaluations to guide your investments
- Automatic Selection
- Stocks/ETF Screener
- Query Builder
- Analyst Screener
- Automated Research Reports
- Best Stocks Filters
- Thematic Stock Screens
- Sector Stock Screens
Learn
Learn

Utilize our extensive educational resources designed to enhance your investing knowledge and skills
- Market News & Insights
- Stock Target Advisor Insights
- Tutorials
- Market News
- Stock Calendars
- Earnings Calendar
- IPO Calendar
- Splits Calendar
Watchlists & Portfolios
Watchlists & Portfolios

Easily manage, track, and optimize your stock selections for maximum returns
Engage
Engage

Connect with the investing community and access free widgets for better stock insights
Pricing

Guessing Isn’t a Strategy!

Use Research That Shows You What to Buy, When to Buy, and Why—Now Upto 70% OFF! Claim Now

Terns Pharmaceuticals Inc (TERN) Financial Statements

COMMON STOCK | Biotechnology | NSD

Target Add to Watchlist

Take a Tour

Strong Buy

Average Analyst
Rating

Slightly Bearish

Stock Target Advisor
Analysis

Hold

Average User
Rating

Last Closing Price

USD 2.71

Change

+0.31 (+12.92%)

Market Cap

USD 0.19B

Volume

1.74M

Avg User Target

USD 11.00 (+305.90%)

TERN

Terns Pharmaceuticals Inc (USD)

COMMON STOCK | NSD

USD 2.71

+0.31 ( +12.92%)

Watchlist

Terns Pharmaceuticals Inc (TERN) Annual Income Statement (USD)

TERN Quarterly Financials (USD)

Frequently Asked Questions About Terns Pharmaceuticals Inc (TERN) Stock

Terns Pharmaceuticals Inc's (TERN) last reported annual revenue was USD 0.00.

Terns Pharmaceuticals Inc's (TERN) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Terns Pharmaceuticals Inc's(TERN) is not profitable as of its last reported annual financials.

The net profit margin for Terns Pharmaceuticals Inc's(TERN) from its laster reported year is N/A

The return on equity (ROE) for Terns Pharmaceuticals Inc's(TERN) from its last reported annual financials is : -29.56%

The return on assets (ROA) for Terns Pharmaceuticals Inc's(TERN) from its last reported annual financials is : -20.13%

The return on invested capital (ROIC) for Terns Pharmaceuticals Inc's(TERN) from its last reported annual financials is : -33.80%

The Debt to Equity ratio for Terns Pharmaceuticals Inc's(TERN) from its last reported annual financials is : 0.00%

The dividend yield for Terns Pharmaceuticals Inc's(TERN) from its laster reported year is 0.00%

Terns Pharmaceuticals Inc's(TERN) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What not to like

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.